Total Funding
90
78
Total FundingFunding Round raised
Growth Score 90 in past quarter
-1 pts
Heat Score 78 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
44063
SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets.
- Leigh Anderson: Co-Founder and Chief Executive Officer
- Terry W. Pearson: Co-Founder and Chief Scientific Officer
About the Company
SISCAPA Assay Technologies, Inc. develops SISCAPA assays for high-value protein biomarkers and other proteins to enable precise measurement of human protein in clinical and other samples. The company offers SISCAPA assay reagents, including RabMAb, which are rabbit monoclonal anti-peptide antibodies; and isotope standard labeled peptides,
unlabelled peptides, and magnetic beads for protein biomarkers. Its products are also used in commercial applications. The company provides SISCAPA licenses the technology to use for commercial research purposes, or to commercialize SISCAPA reagents; and kits or assay services. SISCAPA Assay Technologies, Inc. was incorporated in 2011 and is based in Washin...
Women Founded
Women Led
